Hims & Hers Health launched menopause and low testosterone products in the last month, expanding its addressable market. Read ...

These include the RANKL inhibitor denosumab (Prolia), the anabolic agents teriparatide (Forteo) and abaloparatide (Tymlos), ...

"No answers. No medication. No follow-up call from my primary care physician. Just more pain, more confusion." ...

Physician-led clinic expands medical weight loss, TRT, hair loss treatment and fatty liver care in ...

The US president, Donald Trump, has promised to lower the cost of in vitro fertilisation (IVF) by urging companies that ...

Cardiovascular disease risk may be attributed to factors beyond changes in estrogen among women undergoing the menopause ...